Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Trauma Surg Acute Care Open
Hoofdauteurs: Pumiglia, Luke, Williams, Aaron M, Kemp, Michael T, Wakam, Glenn K, Alam, Hasan B, Biesterveld, Ben E
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2021
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993337/
https://ncbi.nlm.nih.gov/pubmed/33880414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2021-000682
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items